XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$6.95
+0.05 (+0.72%)
Open$7.03
Previous Close$6.90
Day High$7.06
Day Low$6.93
52W High$10.08
52W Low$4.40
Volume—
Avg Volume1.81M
Market Cap1.20B
P/E Ratio99.92
EPS$0.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+571.2% upside
Current
$6.95
$6.95
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 298.55M | 215.79M | 186.74M |
| Net Income | 565.5K | 367.9K | 58.69M |
| Profit Margin | 0.2% | 0.2% | 31.4% |
| EBITDA | 36.56M | 25.11M | 67.69M |
| Free Cash Flow | — | — | 40.84M |
| Rev Growth | +38.4% | +38.4% | +1.9% |
| Debt/Equity | 16.10 | 16.10 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |